Vasoactivity of rucaparib, a PARP-1 inhibitor, is a complex process that involves myosin light chain kinase, P2 receptors, and PARP itself. (Q35092269)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Vasoactivity of rucaparib, a PARP-1 inhibitor, is a complex process that involves myosin light chain kinase, P2 receptors, and PARP itself. |
scientific article |
Statements
Vasoactivity of rucaparib, a PARP-1 inhibitor, is a complex process that involves myosin light chain kinase, P2 receptors, and PARP itself (English)
Cian M McCrudden
Martin G O'Rourke
Kim E Cherry
Hiu-Fung Yuen
Declan O'Rourke
Muhammad Babur
Brian A Telfer
Huw D Thomas
Patrick Keane
Thiagarajan Nambirajan
Chris Hagan
Joe M O'Sullivan
Chris Shaw
17 February 2015
1 reference
1 reference
1 reference